Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $666.12B | 34.5x | 1.34 | $83.11 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $44.48B | 18.3x | 0.69 | $67.18 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $35.80B | 49.8x | -1.03 | $12.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $35.80B | 49.8x | -1.03 | $13.65 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $34.97B | 18.3x | -4.07 | $71.43 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.4% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $34.66B | 18.2x | -6.95 | $37.61 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3% Downside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $34.66B | 18.2x | -6.97 | $37.14 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $33.66B | 25.3x | -0.4 | $96.81 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.8% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $29.57B | 12.8x | -2.59 | $4.45 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $29.57B | 12.8x | -2.59 | $13.38 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.7% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $22.12B | 305.8x | -4.08 | $25.99 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $16.97B | 25.3x | 4.08 | $11.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $15.43B | 29.1x | 2.13 | $415.60 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.4% Upside | Upgrade to Pro+ | |
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $14.38B | 38x | 0.77 | $145.29 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $14.25B | 30x | $61.77 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.3% Upside | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $14.14B | 21.7x | -0.99 | $44.72 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $12.95B | 19.1x | 0.48 | $14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $12.71B | 12.3x | -0.5 | $21.97 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $11.77B | 28.2x | 10.16 | $32.01 | -12.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $11.47B | 29.2x | -3.29 | $73.36 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $11.34B | 29.3x | 4.1 | $59 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.55B | 14.8x | 0.6 | $9.59 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.8% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.55B | 14.8x | 0.6 | $4 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.43B | 12.4x | -0.22 | $2.87 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.4% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.33B | 70.7x | 1.68 | $6.91 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.4% Upside | Upgrade to Pro+ | |
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $9.24B | -1x | 0 | $10.67 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $8.21B | 19.8x | -0.83 | $10.50 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.08B | 34.3x | -1.2 | $12.22 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.04B | 19.8x | 2.45 | $12.86 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $5.78B | 27x | 1.7 | $3.63 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $5.56B | 14.4x | -0.21 | $10.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.88B | 21.7x | -3.26 | $25.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.09B | 28x | 1.99 | $34.95 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $3.21B | 226.3x | 1.78 | $25.27 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $3.06B | -12.7x | 0.02 | $11.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $2.45B | -16.2x | 0.03 | $2.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $2.10B | 19x | 3.21 | $77.72 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $2.02B | 33.9x | 0.77 | $50.01 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.48B | -17.8x | -0.67 | $24.59 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.43B | 25.5x | 0.25 | $32.23 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
[object Object] | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.36B | -11.4x | $21.25 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.4% Upside | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.33B | -9.1x | 0.01 | $8.25 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.33B | 34.5x | -0.66 | $13.69 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.26B | 66.6x | -1.13 | $6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.25B | 23.8x | 0.18 | $5.02 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.18B | 14.9x | -0.27 | $62.01 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.13B | -4.4x | 0 | $6.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $914.79M | 5.2x | 0.03 | $6.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $683.06M | 2,010x | -22.75 | $20.18 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.3% Downside | Upgrade to Pro+ | |
[object Object] | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $533.54M | 9.8x | 2.81 | $36.38 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |